244 related articles for article (PubMed ID: 25216828)
1. Cost-effectiveness of the Three I's for HIV/TB and ART to prevent TB among people living with HIV.
Gupta S; Abimbola T; Date A; Suthar AB; Bennett R; Sangrujee N; Granich R
Int J Tuberc Lung Dis; 2014 Oct; 18(10):1159-65. PubMed ID: 25216828
[TBL] [Abstract][Full Text] [Related]
2. Implementation and Operational Research: Cost-Effectiveness of Antiretroviral Therapy and Isoniazid Prophylaxis to Reduce Tuberculosis and Death in People Living With HIV in Botswana.
Smith T; Samandari T; Abimbola T; Marston B; Sangrujee N
J Acquir Immune Defic Syndr; 2015 Nov; 70(3):e84-93. PubMed ID: 26258564
[TBL] [Abstract][Full Text] [Related]
3. Implementation of Tuberculosis Intensive Case Finding, Isoniazid Preventive Therapy, and Infection Control ("Three I's") and HIV-Tuberculosis Service Integration in Lower Income Countries.
Charles MK; Lindegren ML; Wester CW; Blevins M; Sterling TR; Dung NT; Dusingize JC; Avit-Edi D; Durier N; Castelnuovo B; Nakigozi G; Cortes CP; Ballif M; Fenner L;
PLoS One; 2016; 11(4):e0153243. PubMed ID: 27073928
[TBL] [Abstract][Full Text] [Related]
4. The cost of intensified case finding and isoniazid preventive therapy for HIV-infected patients in Battambang, Cambodia.
Sutton BS; Arias MS; Chheng P; Eang MT; Kimerling ME
Int J Tuberc Lung Dis; 2009 Jun; 13(6):713-8. PubMed ID: 19460246
[TBL] [Abstract][Full Text] [Related]
5. Cost-effectiveness of Preventive Therapy for Tuberculosis With Isoniazid and Rifapentine Versus Isoniazid Alone in High-Burden Settings.
Johnson KT; Churchyard GJ; Sohn H; Dowdy DW
Clin Infect Dis; 2018 Sep; 67(7):1072-1078. PubMed ID: 29617965
[TBL] [Abstract][Full Text] [Related]
6. Re-evaluating the health impact and cost-effectiveness of tuberculosis preventive treatment for modern HIV cohorts on antiretroviral therapy: a modelling analysis using data from Tanzania.
Zhu J; Lyatuu G; Sudfeld CR; Kiravu A; Sando D; Machumi L; Minde J; Chisonjela F; Cohen T; Menzies NA
Lancet Glob Health; 2022 Nov; 10(11):e1646-e1654. PubMed ID: 36240830
[TBL] [Abstract][Full Text] [Related]
7. Intensified tuberculosis case-finding in HIV-positive adults managed at Ethiopian health centers: diagnostic yield of Xpert MTB/RIF compared with smear microscopy and liquid culture.
Balcha TT; Sturegård E; Winqvist N; Skogmar S; Reepalu A; Jemal ZH; Tibesso G; Schön T; Björkman P
PLoS One; 2014; 9(1):e85478. PubMed ID: 24465572
[TBL] [Abstract][Full Text] [Related]
8. Review of policy and status of implementation of collaborative HIV-TB activities in 23 high-burden countries.
Gupta S; Granich R; Date A; Lepere P; Hersh B; Gouws E; Samb B
Int J Tuberc Lung Dis; 2014 Oct; 18(10):1149-58. PubMed ID: 25216827
[TBL] [Abstract][Full Text] [Related]
9. Cost-effectiveness of tuberculosis diagnostic strategies to reduce early mortality among persons with advanced HIV infection initiating antiretroviral therapy.
Abimbola TO; Marston BJ; Date AA; Blandford JM; Sangrujee N; Wiktor SZ
J Acquir Immune Defic Syndr; 2012 May; 60(1):e1-7. PubMed ID: 22240465
[TBL] [Abstract][Full Text] [Related]
10. Microscopic observation drug susceptibility assay for tuberculosis screening before isoniazid preventive therapy in HIV-infected persons.
Reddy KP; Brady MF; Gilman RH; Coronel J; Navincopa M; Ticona E; Chavez G; Sánchez E; Rojas C; Solari L; Valencia J; Pinedo Y; Benites C; Friedland JS; Moore DA
Clin Infect Dis; 2010 Apr; 50(7):988-96. PubMed ID: 20192727
[TBL] [Abstract][Full Text] [Related]
11. Screening for active tuberculosis before isoniazid preventive therapy among HIV-infected West African adults.
Moh R; Badjé A; N'takpé JB; Kouamé GM; Gabillard D; Ouassa T; Ouattara E; Le Carrou J; Bohoussou F; Messou E; Eholié S; Anglaret X; Danel C
Int J Tuberc Lung Dis; 2017 Dec; 21(12):1237-1244. PubMed ID: 29297443
[TBL] [Abstract][Full Text] [Related]
12. Beneficial effect of isoniazid preventive therapy and antiretroviral therapy on the incidence of tuberculosis in people living with HIV in Ethiopia.
Yirdaw KD; Jerene D; Gashu Z; Edginton ME; Kumar AM; Letamo Y; Feleke B; Teklu AM; Zewdu S; Weiss B; Ruff A
PLoS One; 2014; 9(8):e104557. PubMed ID: 25105417
[TBL] [Abstract][Full Text] [Related]
13. The protective effect of isoniazid preventive therapy on tuberculosis incidence among HIV positive patients receiving ART in Ethiopian settings: a meta-analysis.
Geremew D; Endalamaw A; Negash M; Eshetie S; Tessema B
BMC Infect Dis; 2019 May; 19(1):405. PubMed ID: 31077133
[TBL] [Abstract][Full Text] [Related]
14. The cost-effectiveness of tuberculosis preventive therapy for HIV-infected individuals in southern India: a trial-based analysis.
Pho MT; Swaminathan S; Kumarasamy N; Losina E; Ponnuraja C; Uhler LM; Scott CA; Mayer KH; Freedberg KA; Walensky RP
PLoS One; 2012; 7(4):e36001. PubMed ID: 22558301
[TBL] [Abstract][Full Text] [Related]
15. Early-phase scale-up of isoniazid preventive therapy for people living with HIV in two districts in Malawi (2017).
Nabity SA; Gunde LJ; Surie D; Shiraishi RW; Kirking HL; Maida A; Auld AF; Odo M; Jahn A; Nyirenda RK; Oeltmann JE
PLoS One; 2021; 16(4):e0248115. PubMed ID: 33793577
[TBL] [Abstract][Full Text] [Related]
16. Cost-Effectiveness of isoniazid preventive therapy among HIV-infected patients clinicaly screened for latent tuberculosis infection in Dar es Salaam, Tanzania: A prospective Cohort study.
Shayo GA; Chitama D; Moshiro C; Aboud S; Bakari M; Mugusi F
BMC Public Health; 2017 Jul; 18(1):35. PubMed ID: 28724374
[TBL] [Abstract][Full Text] [Related]
17. Xpert® MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults.
Steingart KR; Schiller I; Horne DJ; Pai M; Boehme CC; Dendukuri N
Cochrane Database Syst Rev; 2014 Jan; 2014(1):CD009593. PubMed ID: 24448973
[TBL] [Abstract][Full Text] [Related]
18. Cost-effectiveness of isoniazid preventive therapy for HIV-infected pregnant women in India.
Kapoor S; Gupta A; Shah M
Int J Tuberc Lung Dis; 2016 Jan; 20(1):85-92. PubMed ID: 26688533
[TBL] [Abstract][Full Text] [Related]
19. CD4+ cell count stratification to guide tuberculosis preventive therapy for people living with HIV.
Chaisson LH; Saraceni V; Cohn S; Seabrook D; Cavalcante SC; Chaisson RE; Golub JE; Durovni B
AIDS; 2020 Jan; 34(1):139-147. PubMed ID: 31634189
[TBL] [Abstract][Full Text] [Related]
20. Delayed diagnosis and treatment of tuberculosis in HIV+ patients in Mozambique: A cost-effectiveness analysis of screening protocols based on four symptom screening, smear microscopy, urine LAM test and Xpert MTB/RIF.
Orlando S; Triulzi I; Ciccacci F; Palla I; Palombi L; Marazzi MC; Giuliano M; Floridia M; Mancinelli S; Mutemba E; Turchetti G
PLoS One; 2018; 13(7):e0200523. PubMed ID: 30024890
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
